These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15500414)

  • 1. Rosuvastatin safety: lessons from the FDA review and post-approval surveillance.
    Davidson MH
    Expert Opin Drug Saf; 2004 Nov; 3(6):547-57. PubMed ID: 15500414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care.
    García-Rodríguez LA; Massó-González EL; Wallander MA; Johansson S
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):943-52. PubMed ID: 18425988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases.
    García-Rodríguez LA; González-Pérez A; Stang MR; Wallander MA; Johansson S
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):953-61. PubMed ID: 18425987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
    McKenney JM
    Am J Health Syst Pharm; 2005 May; 62(10):1033-47. PubMed ID: 15901588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin and the statin wars--the way to peace.
    Meyboom RH; Edwards IR
    Lancet; 2004 Dec 4-10; 364(9450):1997-9. PubMed ID: 15582043
    [No Abstract]   [Full Text] [Related]  

  • 6. Rosuvastatin: an independent analysis of risks and benefits.
    Zipes DP; Zvaifler NJ; Glassock RJ; Gilman S; Muñoz A; Gogolak V; Gordis L; Dedon PC; Guengerich FP; Wasserman SI; Witztum JL; Wogan GN
    MedGenMed; 2006 Jun; 8(2):73. PubMed ID: 16926812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins.
    García Rodríguez LA; Herings R; Johansson S
    Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1218-24. PubMed ID: 20922707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin: renal disorders and rhabdomyolysis.
    Prescrire Int; 2007 Apr; 16(88):68-9. PubMed ID: 17458050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of rosuvastatin.
    Olsson GO
    Lancet; 2004 Jul 10-16; 364(9429):135. PubMed ID: 15246717
    [No Abstract]   [Full Text] [Related]  

  • 10. Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.
    Ferdinand KC
    Expert Opin Pharmacother; 2005 Sep; 6(11):1897-910. PubMed ID: 16144509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The statin wars.
    McKillop T
    Lancet; 2003 Nov; 362(9394):1498. PubMed ID: 14602449
    [No Abstract]   [Full Text] [Related]  

  • 12. The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis.
    Alsheikh-Ali AA; Ambrose MS; Kuvin JT; Karas RH
    Circulation; 2005 Jun; 111(23):3051-7. PubMed ID: 15911706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of rosuvastatin.
    Shepherd J; Hunninghake DB; Stein EA; Kastelein JJ; Harris S; Pears J; Hutchinson HG
    Am J Cardiol; 2004 Oct; 94(7):882-8. PubMed ID: 15464670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.
    Kostapanos MS; Milionis HJ; Elisaf MS
    Am J Cardiovasc Drugs; 2010; 10(1):11-28. PubMed ID: 20104931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study.
    Goettsch WG; Heintjes EM; Kastelein JJ; Rabelink TJ; Johansson S; Herings RM
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):435-43. PubMed ID: 16761304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program.
    Shepherd J; Vidt DG; Miller E; Harris S; Blasetto J
    Cardiology; 2007; 107(4):433-43. PubMed ID: 17363845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy.
    McAfee AT; Ming EE; Seeger JD; Quinn SG; Ng EW; Danielson JD; Cutone JA; Fox JC; Walker AM
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):444-53. PubMed ID: 16761308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin: winner in the statin wars, patients' health notwithstanding.
    Wolfe S
    BMJ; 2015 Mar; 350():h1388. PubMed ID: 25787130
    [No Abstract]   [Full Text] [Related]  

  • 19. McArdle disease with rhabdomyolysis induced by rosuvastatin: case report.
    Lorenzoni PJ; Silvado CE; Scola RH; Luvizotto M; Werneck LC
    Arq Neuropsiquiatr; 2007 Sep; 65(3B):834-7. PubMed ID: 17952291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myopathy caused by a combination rosuvastatin and fenofibrate.
    Dedhia V; Munsi SC
    J Assoc Physicians India; 2007 Feb; 55():152-3. PubMed ID: 17571748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.